Exploring new treatments to protect vision in glaucoma patients
Kinase Multitargeting for Glaucoma Neuroprotection
This study is looking at ways to help protect your eyesight from glaucoma by finding new treatments that work alongside the usual eye pressure medications, focusing on important proteins that can help keep your vision cells healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11004696 on NIH RePORTER |
What this research studies
This research focuses on glaucoma, a condition that damages the optic nerve and can lead to vision loss. The team is investigating neuroprotective strategies that could work alongside existing treatments that lower eye pressure. They are using advanced techniques to identify key proteins involved in protecting retinal ganglion cells, which are crucial for vision. By studying these proteins, the researchers aim to develop new therapies that could prevent cell death and promote recovery in patients with glaucoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with glaucoma who may not respond well to current pressure-lowering therapies.
Not a fit: Patients with glaucoma who have already experienced significant vision loss or those with other unrelated eye conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that protect vision and improve outcomes for glaucoma patients.
How similar studies have performed: Previous research has shown promising results in protecting retinal cells using similar neuroprotective approaches, indicating potential for success in this area.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Welsbie, Derek Stuart — University of California, San Diego
- Study coordinator: Welsbie, Derek Stuart
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.